Regulation, regulation, regulation

episode

Medicine and Science from The BMJ not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Tom Cruise Pulled His Own Tooth Out w/ Rob Lowe | 2 Bears, 1 Cave 1h 52m · 28 Sep 2026 · 2 Bears, 1 Cave with Tom Segura & Bert Kreischer

Key Saudi Arabian Pipeline Starts Exports, Nvidia’s AI System, More 7 min · 28 Sep 2026 · Bloomberg News Now

Bonus Episode: Caitríona Balfe on Sense & Sensibility 24 min · 28 Sep 2026 · The Women's Podcast

Mister Petty 2h 51m · 28 Sep 2026 · UNspoiled! The Dresden Files

The Day You Stop Playing It Safe, Everything Changes 44 min · 28 Sep 2026 · Your World Within Podcast by Eddie Pinero

Azerbaijan GP Driver Ratings 1h 9m · 28 Sep 2026 · P1 with Matt and Tommy

Report any issue

Source

Recorded28 Aug 2013

Publisherfeed.podbean.com ↗

Handlerec:13498775

Show notes

A BMJ investigation this week raises concerns about the ability of the US Food and Drug Administration to monitor the safety of medical devices through post-approval surveillance. We ask: is the FDA giving device manufacturers an easy regulatory ride? Also, the National Institute for Health and Clinical Excellence (NICE) is set to lose the power to restrict the use of any drug that exceeds its £30k cost per quality adjusted life year ceiling. Alan Maynard, professor of health economics at the University of York, discusses what this will mean.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in